Menu
GeneBe

rs760941

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001008216.2(GALE):c.873+13G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000945 in 1,392,538 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 14)
Exomes 𝑓: 0.00092 ( 1 hom. )

Consequence

GALE
NM_001008216.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.798
Variant links:
Genes affected
GALE (HGNC:4116): (UDP-galactose-4-epimerase) This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and cognitive disability, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-23796496-C-G is Benign according to our data. Variant chr1-23796496-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 402890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00127 (138/108690) while in subpopulation NFE AF= 0.00185 (97/52450). AF 95% confidence interval is 0.00155. There are 2 homozygotes in gnomad4. There are 69 alleles in male gnomad4 subpopulation. Median coverage is 14. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GALENM_001008216.2 linkuse as main transcriptc.873+13G>C intron_variant ENST00000617979.5
GALENM_000403.4 linkuse as main transcriptc.873+13G>C intron_variant
GALENM_001127621.2 linkuse as main transcriptc.873+13G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GALEENST00000617979.5 linkuse as main transcriptc.873+13G>C intron_variant 1 NM_001008216.2 P1Q14376-1

Frequencies

GnomAD3 genomes
AF:
0.00126
AC:
137
AN:
108624
Hom.:
2
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.000664
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000634
Gnomad ASJ
AF:
0.00145
Gnomad EAS
AF:
0.000805
Gnomad SAS
AF:
0.00115
Gnomad FIN
AF:
0.000417
Gnomad MID
AF:
0.00410
Gnomad NFE
AF:
0.00185
Gnomad OTH
AF:
0.000694
GnomAD3 exomes
AF:
0.00156
AC:
350
AN:
224046
Hom.:
0
AF XY:
0.00139
AC XY:
170
AN XY:
122282
show subpopulations
Gnomad AFR exome
AF:
0.000926
Gnomad AMR exome
AF:
0.000851
Gnomad ASJ exome
AF:
0.000637
Gnomad EAS exome
AF:
0.00145
Gnomad SAS exome
AF:
0.000986
Gnomad FIN exome
AF:
0.00292
Gnomad NFE exome
AF:
0.00193
Gnomad OTH exome
AF:
0.000906
GnomAD4 exome
AF:
0.000918
AC:
1178
AN:
1283848
Hom.:
1
Cov.:
36
AF XY:
0.000887
AC XY:
568
AN XY:
640066
show subpopulations
Gnomad4 AFR exome
AF:
0.000184
Gnomad4 AMR exome
AF:
0.000896
Gnomad4 ASJ exome
AF:
0.000132
Gnomad4 EAS exome
AF:
0.000641
Gnomad4 SAS exome
AF:
0.000531
Gnomad4 FIN exome
AF:
0.00158
Gnomad4 NFE exome
AF:
0.000962
Gnomad4 OTH exome
AF:
0.000961
GnomAD4 genome
AF:
0.00127
AC:
138
AN:
108690
Hom.:
2
Cov.:
14
AF XY:
0.00131
AC XY:
69
AN XY:
52594
show subpopulations
Gnomad4 AFR
AF:
0.000701
Gnomad4 AMR
AF:
0.000633
Gnomad4 ASJ
AF:
0.00145
Gnomad4 EAS
AF:
0.000807
Gnomad4 SAS
AF:
0.00115
Gnomad4 FIN
AF:
0.000417
Gnomad4 NFE
AF:
0.00185
Gnomad4 OTH
AF:
0.000689

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

UDPglucose-4-epimerase deficiency Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 19, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Same variant as above. Gene associated with epimerase deficiency galactosemia - Infants with the profound generalized form who are on a diet containing galactose/lactose manifest hypotonia, poor feeding, vomiting, weight loss, jaundice, hepatomegaly, liver dysfunction, aminoaciduria, and cataracts. Frequency and location of variant suggest benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
Cadd
Benign
0.78
Dann
Benign
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760941; hg19: chr1-24122986; COSMIC: COSV65720422; COSMIC: COSV65720422; API